EEG Feature Extraction for TMS Efficacy Prediction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for depression, particularly transcranial magnetic stimulation, are not universally effective and are costly, leading to ineffective treatments and high medical expenses due to the lack of a reliable method to determine efficacy before administration.

Innovation Solution

An auxiliary determination device that extracts feature values from electroencephalography signals using a machine learning unit, comprising a feature extraction unit, signal pre-processing unit, and frequency band screening unit, to evaluate the effectiveness of transcranial magnetic stimulation and adjust parameters for personalized treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If transcranial magnetic stimulation is used to treat depression, then treatment period is significantly shorter than drugs or psychological counseling, but the treatment cost is higher and not effective for every patient

Engineering Contradiction:
Improvetreatment periodVSAvoidtreatment efficacy
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The system performs preliminary analysis of EEG signals before TMS treatment to predict treatment efficacy. By extracting features from EEG signals and inputting them into a trained machine learning model, the system determines in advance whether a patient is likely to respond well to TMS therapy, allowing doctors to avoid ineffective treatments and select appropriate candidates before administering the expensive treatment.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If transcranial magnetic stimulation parameters are adjusted to generate r-TMS or i-TBS, then treatment effectiveness may be improved, but the complexity of parameter settings increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidparameter settings complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system automatically determines the appropriate TMS parameters based on the patient's EEG signal characteristics and the pre-trained machine learning model. Instead of requiring doctors to manually adjust multiple parameters, the system self-service by selecting optimal parameters (such as frequency, intensity, and pulse pattern) based on the patient's neural activity patterns, thereby simplifying the operation while maintaining treatment effectiveness.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system changes TMS parameters dynamically based on individual patient characteristics extracted from EEG signals. The machine learning model analyzes features such as brain wave frequencies and patterns to automatically adjust parameters like stimulation frequency, pulse width, and intensity to match the patient's specific neural characteristics, thereby optimizing treatment effectiveness without requiring manual parameter tuning.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If EEG signal analysis is performed with multiple processing steps including pre-processing, feature extraction, and frequency band screening, then evaluation accuracy is improved, but the system complexity increases

Engineering Contradiction:
Improveevaluation accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The signal analysis system is divided into distinct functional modules: pre-processing unit for noise reduction and signal conditioning, feature extraction unit for identifying relevant EEG characteristics, frequency band screening unit for isolating specific frequency ranges, and classification unit for predicting treatment response. This segmentation allows each module to perform its specific function efficiently while maintaining overall system manageability and evaluation accuracy.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20230346294A1Auxiliary determination device for evaluating efficacy of transcranial magnetic stimulation for patient with depression
Publication Date: 2023.11.02 LI CHENG-TA
  • US20230346294A1 patent drawing
  • US20230346294A1 patent drawing
  • US20230346294A1 patent drawing

AI summary

An auxiliary determination device for evaluating whether a transcranial magnetic stimulation (TMS) is effective for a patient with depression is provided. The device includes a feature extraction unit and a machine learning unit electrically connected thereto. In an interpretation mode, the feature extraction unit extracts a feature value from electroencephalography signals of the patient, and at least a classifier of the machine learning unit determines the efficacy of TMS for the patient according to the feature value of the electroencephalography signals. The electroencephalography signals are electroencephalography signals of the patient after being driven by a cognitive operation or a difference between electroencephalography signals before and after being driven by the cognitive operation, and the feature value is a linear or non-linear feature value. The auxiliary determination device of the invention can pre-evaluate the efficacy of TMS for the patient for avoiding ineffective treatment and unnecessary medical expense.